Related Experiment Video
Updated: Apr 25, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
A current understanding of vascular calcification in CKD
Neil J Paloian1, Cecilia M Giachelli2
1Division of Nephrology, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington; and.
Insights
Vascular calcification in chronic kidney disease (CKD) and end-stage renal disease (ESRD) contributes to cardiovascular risks. Understanding its mechanisms is key to developing new treatments.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Biochemistry
Background:
- Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) face high rates of cardiovascular morbidity and mortality.
- Vascular calcification is a significant contributor to this increased cardiovascular risk in CKD and ESRD patients.
- Vascular calcification is a complex, regulated process resembling bone formation.
Purpose of the Study:
- To review the current understanding of the mechanisms underlying vascular calcification in CKD.
- To highlight recent discoveries in extracellular vesicles, microRNAs, and calciprotein particles relevant to vascular calcification.
- To emphasize the need for further research to develop biomarkers and therapies for CKD-related vascular calcification.
Main Methods:
- Literature review of recent discoveries in vascular calcification.
- Analysis of mechanisms involving extracellular vesicles, microRNAs, and calciprotein particles.
- Synthesis of current knowledge on vascular calcification in CKD and ESRD.
Main Results:
- Vascular calcification is an active, regulated process with similarities to bone formation.
- Extracellular vesicles, microRNAs, and calciprotein particles are increasingly recognized as key players in vascular calcification.
- These mechanisms offer potential targets for future therapeutic interventions.
Conclusions:
- Continued innovation in understanding extracellular vesicles, microRNAs, and calciprotein particles is crucial.
- Developing novel biomarkers and therapeutic strategies for vascular calcification in CKD and ESRD is a critical unmet need.
- Further research is essential to mitigate cardiovascular complications in kidney disease patients.
Abstract:
Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) have significant cardiovascular morbidity and mortality that is in part due to the development of vascular calcification. Vascular calcification is an active, highly regulated process that shares many similarities with normal bone formation. New discoveries related to extracellular vesicles, microRNAs, and calciprotein particles continue to reveal the mechanisms that are involved in the initiation and progression of vascular calcification in CKD. Further innovations in these fields are critical for the development of biomarkers and therapeutic options for patients with CKD and ESRD.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury II: Pathophysiology
Diabetic Nephropathy

